ArticleJournal of rheumatic diseases2021

Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a

Wook-Young Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.